Kliininen tutkimuskeskus
Clinical Research Center

Julkaisut 2007
Publications 2007

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Andrulionyté L et al. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes. The STOP-NIDDM Trial.
2 Bondestam J et al. Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.
3 Clarke J et al. Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats.
4 Dahlman I et al. A common haplotype in the G-protein-coupled receptor gene GPR74 is associated with leanness and increased lipolysis.
5 Erdmann E et al. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease. Data from the PROactive Study (PROactive 08).
6 Haara MM et al. Relative bone mineral density measured by metacarpal index (MCI) and chronic spinal syndromes: an epidemiological study.
7 Heinonen SE et al. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
8 Helisalmi S. Lipid profile factors and apolipoprotein E polymorphism in Alzheimer´s disease.
9 Herukka S-K et al. CSF Abeta42, tau and phosphorylated tau, APOE epsilon4 allele and MCI type in progressive MCI.
10 Hämäläinen A et al. Increased fMRI responses during encoding in mild cognitive impairment.
11 Hämäläinen A et al. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.
12 Joukainen A et al. Bioabsorbable screw fixation for the treatment of ankle fractures.
13 Karhunen H et al. Epileptogenesis after cortical photothrombotic brain lesion in rats.
14 Kilpeläinen TO et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.
15 Korolainen MA et al. Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease.
16 Kröger H. Päivittäin vai harvemmin? Bisfosfonaattilääkityksen toteutuminen osteoporoosin hoidossa.
17 Kröger H. Murtumariskin arviointi luuntiheysmittauksilla - miksi, miten ja kenelle?
18 Kuusisto J et al. Atherosclerosis and cardiovascular risk reduction with PPAR agonists.
19 Laakso M. Sirtuiinit - energiatasapainon ja glukoosimetabolian uudet molekyylit.
20 Laakso M. Diabetes - glukoosiaineenvaihdunnan säätelyn perinnöllinen häiriö.
21 Lämsä R et al. Study on the association between SOAT1 polymorphisms, Alzheimer´s disease risk and the level of CSF biomarkers.
22 Lämsä R et al. The association study between DHCR24 polymorphisms and Alzheimer's disease.
23 Ngandu T et al. Education and dementia: What lies behind the association?
24 Paimela T et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells.
25 Pirinen E et al. Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism.
26 Rovio S et al. Work-related physical activity and the risk of dementia and Alzheimer's disease.
27 Rutanen J et al. Single nucleotide polymorphisms of the melanocortin-3 receptor gene are associated with substrate oxidation and first-phase insulin secretion in offspring of type 2 diabetic subjects.
28 Saarelainen J et al. Is discordance in bone measurements affected by body composition or anthropometry? A comparative study between peripheral and central devices.
29 Sakka P et al. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
30 Soininen H et al. Long-term efficacy and safety of celecoxib in Alzheimer´s disease.
31 Staiger H et al. Genetic variation within the APPL locus is not associated with metabolic or inflammatory traits in a healthy white population.
32 Stefan N et al. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic pysical fitness and insulin sensitivity during lifestyle intervention.
33 Tamminen I et al. Luubiopsian histomorfometrinen tutkimus metabolisten luusairauksien diagnostiikassa.
34 Tuunanen H et al. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
35 Vepsäläinen S. A Molecular Genetic Study and Expression-Based Analysis of Risk Factors of Alzheimer's Disease. Emphasis on AB-degrading Enzymes, IDE and NEP.
36 Vepsäläinen S et al. Somatostatin genetic variants modify the risk for Alzheimer´s disease among finnish patients.
37 Vepsäläinen S et al. Insulin-degrading enzyme is genetically associated wirh Alzheimer's disease in the finnish population.
38 Wang J et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.

Kliininen tutkimuskeskus Clinical Research Center
Julkaisutietokanta 18.6.2008 Publications Data Base 18.6.2008